Article
Hypoxia selects for androgen independent LNCaP cells with a more malignant geno- and phenotype.
International journal of cancer - 15 Aug 2008
Butterworth Karl T, McCarthy Helen O, Devlin Andrea, Ming Louise, Robson Tracy, McKeown Stephanie R, Worthington Jenny
Abstract excerpt
Hypoxia confers resistance to common cancer therapies, however, it has also has been shown to result in genetic alterations which may allow a survival advantage and increase the tumorigenic properties of cancer cells. Additionally, it may exert a selection pressure, allowing expansion of tumor cells with a more aggressive phenotype. To further assess the role of hypoxia in malignant progression in prostate cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
